Patents
Nature Biotechnology 25, 1105 - 1106 (2007)
doi:10.1038/nbt1007-1105
Obviousness, hindsight and perspective: the impact of KSR v. Teleflex on biotech and pharmaceutical patents
Rachel Teitelbaum1 & Mark Cohen1
Abstract
A recent Supreme Court decision has introduced some uncertainty regarding the determination of obviousness of an invention.
- Rachel Teitelbaum and Mark Cohen are at Pearl Cohen Zedek Latzer LLP, 1500 Broadway, 12th Floor, New York, New York 10036, USA. e-mail: rachelt@pczlaw.com

